Steris (STE) Change in Account Payables (2018 - 2026)
Steris (STE) recorded quarterly Change in Account Payables of $56.9 million in Q1 2026, up 297.57% quarter-over-quarter from -$28.8 million in Q4 2025, and up 38.44% on a YoY basis from $41.1 million in Q1 2025.
Steris (STE) Change in Account Payables (2018 - 2026) Analysis & Trends
Steris' Change in Account Payables history runs 9 years deep, the most recent figure standing at $56.9 million for Q1 2026.
- In Q1 2026, Change in Account Payables rose 38.44% year-over-year to $56.9 million; the TTM figure through Mar 2026 stood at $51.1 million (up 52.08% YoY), while the FY2026 annual figure was $51.1 million, up 52.08% from the prior year.
- Change in Account Payables was $56.9 million for Q1 2026 at Steris, up from -$28.8 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $56.9 million in Q1 2026 to a low of -$28.8 million in Q4 2025.
- Historically, Change in Account Payables has averaged $8.5 million across 5 years, with a median of $8.8 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Change in Account Payables tumbled 773.44% in 2023, then surged 1550.0% in 2025.
- A 5-year view of Change in Account Payables shows it stood at $3.1 million in 2022, then sank by 773.44% to -$21.2 million in 2023, then surged by 141.56% to $8.8 million in 2024, then slumped by 427.27% to -$28.8 million in 2025, then surged by 297.57% to $56.9 million in 2026.
- The last three Change in Account Payables figures came in at $56.9 million (Q1 2026), -$28.8 million (Q4 2025), and $13.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56.90 Mn |
| Mar 31, 2026 | 56.90 Mn |
| Dec 31, 2025 | -28.80 Mn |
| Dec 31, 2025 | -28.80 Mn |
| Sep 30, 2025 | 13.20 Mn |
| Sep 30, 2025 | 13.20 Mn |
| Jun 30, 2025 | 9.80 Mn |
| Jun 30, 2025 | 9.80 Mn |
| Mar 31, 2025 | 41.10 Mn |
| Mar 31, 2025 | 41.10 Mn |
| Dec 31, 2024 | 8.80 Mn |
| Dec 31, 2024 | 8.80 Mn |
| Sep 30, 2024 | 800,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | -17.10 Mn |
| Jun 30, 2024 | -17.10 Mn |
| Mar 31, 2024 | -12.90 Mn |
| Mar 31, 2024 | -12.90 Mn |
| Dec 31, 2023 | -21.17 Mn |
| Dec 31, 2023 | -21.17 Mn |